SlideShare a Scribd company logo
Diagnosis and management
of Hypertension
Hypertension is defined as systolic blood
pressure (SBP) of 140 mmHg or greater,
diastolic blood pressure (DBP) of
90 mmHg or greater, or taking
antihypertensive medication.
Types of hypertension
• Essential hypertension
– 95%
– No underlying cause
• Secondary hypertension
– Underlying cause
Causes of
Secondary Hypertension
• Renal
– Parenchymal
– Vascular
– Others
• Endocrine
• Miscellaneous
• Unknown
Classification
Blood Pressure
Classification
Normal <120 and <80
Prehypertension 120–139 or 80–89
Stage 1
Hypertension
140–159 or 90–99
Stage 2
Hypertension
>160 or >100
BP
Classification
SBP
mmHg
DBP
mmHg
Incidence in India
• 25% of urban population and 10 % of rural
population suffer from hypertension
• 70% of all hypertensive patients are stage I
hypertension
• 12% of all hypertensive suffer from isolated systolic
hypertension
Who are at risk ?
Hypertension:
Predisposing factors
• Advancing Age
• Sex (men and postmenopausal women)
• Family history of cardiovascular disease
• Sedentary life style & psycho-social stress
• Smoking ,High cholesterol diet, Low fruit
consumption
• Obesity & wt. gain
• Co-existing disorders such as diabetes, and
hyperlipidaemia
• High intake of alcohol
Haemodynamic Pattern
in Hypertension
Young :  BP = CO X TPR
Elderly :  BP =  CO X   TPR
Aetiology of Systemic
Hypertension
Secondary HTN (05%)
A. Renal (80%) • AGN
• CGN,
• CPN,
• Polycyst. K.D
• Renal Artery stenosis
B. Endocrine • Adrenal • Primary aldosteronism
• Cushing’s syndrome
• Pheochromocytoma
• Acromegaly
• Exogenous hormone • Oral contraceptive
• Glucocorticoids
• Hypothyroidism &
• Hyperparathyroidism
Continue…
Others
– Coarctation of the aorta
– Pregnancy Induced HTN (Pre-eclampsia)
– Sleep Apnea Syndrome.
Aetiology of
Systemic Hypertension
Why to treat ?
Diseases Attributable to
Hypertension
HYPERTENSION
Gangrene of the
Lower Extremities
Heart
Failure
Left Ventricular
Hypertrophy Myocardial
Infarction
Coronary Heart
Disease
Aortic
Aneurym
Blindness
Chronic
Kidney
Failure
Stroke Preeclampsia/
Eclampsia
Cerebral
Hemorrhage
Hypertensive
encephalopathy
Adapted from Dustan HP et al. Arch Intern Med. 1996; 156: 1926-1935
Target Organ Damage
 Heart
• Left ventricular hypertrophy
• Angina or myocardial infarction
• Heart failure
 Brain
• Stroke or transient ischemic attack
 Chronic kidney disease
 Peripheral arterial disease
 Retinopathy
CVD Risk
 The BP relationship to risk of CVD is continuous,
consistent, and independent of other risk factors.
 Prehypertension signals the need for increased
education to reduce BP in order to prevent
hypertension.
Diagnosis
Clinical manifestations
• No specific complains or manifestations other than
elevated systolic and/or diastolic BP (Silent Killer )
• Morning occipital headache
• Dizziness
• Fatigue
• In severe hypertension, epistaxis or blurred vision
Self-Measurement of BP
 Provides information on:
1. Response to antihypertensive therapy
2. Improving adherence with therapy
3. Evaluating white-coat HTN
 Home measurement of >135/85 mmHg is generally
considered to be hypertensive.
 Home measurement devices should be checked
regularly.
Measuring
Blood Pressure
• Patient seated quietly for at least
5minutes in a chair, with feet on the
floor and arm supported at heart
level
•An appropriate-sized cuff (cuff bladder encircling at least
80% of the arm)
•At least 2 measurements
Continue…
• Systolic Blood Pressure is the point at which
the first of 2 or more sounds is heard
• Diastolic Blood Pressure is the point of
disappearance of the sounds (Korotkoff 5th)
Continue…
Measuring
Blood Pressure
• Ambulatory BP Monitoring - information about
BP during daily activities and sleep.
• Correlates better than office measurements
with target-organ injury.
Continue…
Measuring
Blood Pressure
How to treat ?
Treatment Overview
Goals of therapy
Lifestyle modification
Pharmacologic treatment
 Algorithm for treatment of hypertension
Follow up and monitoring
Goals of Therapy
Reduce Cardiac and renal morbidity and mortality.
Treat to BP <140/90 mmHg or BP <130/80 mmHg in
patients with diabetes or chronic kidney disease.
Non pharmacological
Treatment of hypertension
Avoid harmful habits ,smoking ,alcohal
Reduce salt and high fat diets
Loose weight , if obese
Regular exercise
DASH
diet
Life style modifications
• Lose weight, if overweight
• Increase physical activity
• Reduce salt intake
• Stop smoking
• Limit intake of foods rich in fats and
cholesterol
• increase consumption of fruits and
vegetables
• Limit alcohol intake
Lifestyle Modification
Modification Approximate SBP reduction
(range)
Weight reduction 5–20 mmHg / 10 kg weight loss
Adopt DASH eating
plan
8–14 mmHg
Dietary sodium
reduction
2–8 mmHg
Physical activity 4–9 mmHg
Moderation of alcohol
consumption
2–4 mmHg
Antihypertensive Drugs
Continue….
AT1 receptor
ARB
Drug therapy for hypertension
Class of drug Example Initiating dose Usualmaintenance
dose
Diuretics Hydrochlorothiazide 12.5 mg o.d. 12.5-25 mg o.d.
-blockers Atenolol 25-50 mg o.d. 50-100 mg o.d.
Calcium Amlodipine 2.5-5 mg o.d. 5-10 mg o.d.
channel
blockers
-blockers prazosin 2.5 mg o.d 2.5-10mg o.d.
ACE- inhibitors ramipril 1.25-5 mg o.d. 5-20 mg o.d.
Angiotensin-II Losartan 25-50 mg o.d. 50-100 mg o.d.
receptor blockers
Diuretics
Example: Hydrochlorothiazide
• Act by decreasing blood volume and cardiac output
• Decrease peripheral resistance during chronic therapy
• Drugs of choice in elderly hypertensives
Side effects-
• Hypokalaemia
• Hyponatraemia
• Hyperlipidaemia
• Hyperuricaemia (hence contraindicated in gout)
• Hyperglycaemia (hence not safe in diabetes)
• Not safe in renal and hepatic insufficiency
Beta blockers
Example: Atenolol, Metoprolol, nebivolol,
• Block 1 receptors on the heart
• Block 2 receptors on kidney and inhibit release of renin
• Decrease rate and force of contraction and thus reduce
cardiac output
• Drugs of choice in patients with co-existent coronary
heart disease
Side effects-
• lethargy, impotency, bradycardia
• Not safe in patients with co-existing asthma and
diabetes
• Have an adverse effect on the lipid profile
Calcium channel blockers
Example: Amlodipine
• Block entry of calcium through calcium channels
• Cause vasodilation and reduce peripheral
resistance
• Drugs of choice in elderly hypertensives and
those with co-existing asthma
• Neutral effect on glucose and lipid levels
Side effects
Flushing, headache, Pedal edema
ACE inhibitors
Example: Ramipril, Lisinopril, Enalapril
• Inhibit ACE and formation of angiotensin II
and block its effects
• Drugs of choice in co-existent diabetes
mellitus, Heart failure
Side effects-
dry cough, hypotension, angioedema
Angiotensin II receptor
blockers
Example: Losartan
• Block the angiotensin II receptor and
inhibit effects of angiotensin II
• Drugs of choice in patients with co-
existing diabetes mellitus
Side effects-
safer than ACEI, hypotension,
Alpha blockers
Example: prazosin
• Block -1 receptors and cause vasodilation
• Reduce peripheral resistance and venous
return
• Exert beneficial effects on lipids and insulin
sensitivity
• Drugs of choice in patients with co-existing
BPH
Side effects-
Postural hypotension,
Antihypertensive therapy:
Side-effects and Contraindications
Class of drugs Main side-effects Contraindications/
Special Precautions
Diuretics Electrolyte imbalance, Hypersensitivity,
Anuria
(e.g. Hydrochloro- total and LDL cholesterol
thiazide) levels, HDL cholesterol
levels, glucose levels,
uric acid levels
-blockers Impotence, Bradycardia,
(e.g. Atenolol) Fatigue Bradycardia,
Conduction
disturbances,
Diabetes,
Asthma, Severe
cardiac
failure
Algorithm for
Treatment of Hypertension
Not at Goal Blood Pressure (<140/90 mmHg)
(<130/80 mmHg for those with diabetes or chronic kidney disease)
Initial Drug Choices
Drug(s) for the compelling
indications
Other antihypertensive drugs (diuretics,
ACEI, ARB, BB, CCB)
as needed.
With Compelling
Indications
Lifestyle Modifications
Stage 2 Hypertension
(SBP >160 or DBP >100 mmHg)
2-drug combination for most (usually
thiazide-type diuretic and
ACEI, or ARB, or BB, or CCB)
Stage 1 Hypertension
(SBP 140–159 or DBP 90–99 mmHg)
Thiazide-type diuretics for most.
May consider ACEI, ARB, BB, CCB,
or combination.
Without Compelling
Indications
Not at Goal
Blood Pressure
Optimize dosages or add additional drugs
until goal blood pressure is achieved.
Consider consultation with hypertension specialist.
Choice of Drug
Condition Preferred drugs Other drugs Drugs to be
that can be used avoided
Asthma Calcium channel -blockers/Angiotensin-II -blockers
blockers receptor blockers/Diuretics/
ACE-inhibitors
Diabetes -blockers/ACE Calcium channel blockers Diuretics/
mellitus inhibitors/ -blockers
Angiotensin-II
receptor blockers
High cholesterol -blockers ACE inhibitors/ A-II -blockers/
levels receptor blockers/ Calcium Diuretics
channel blockers
Elderly patients Calcium channel -blockers/ACE-
(above 60 years) blockers/Diuretics inhibitors/Angiotensin-II
receptor blockers/- blockers
BPH -blockers -blockers/ ACE inhibitors/
Angiotensin-II receptor
blockers/ Diuretics/
Calcium channel blockers
Class of drug Main side-effects Contraindications/ Special
Precautions
Calcium channel blockers Pedal edema, Headache Non-dihydropyridine
(e.g. Amlodipine, CCBs (e.g diltiazem)–
Diltiazem) Hypersensitivity,
Bradycardia, Conduction
disturbances, CHF, LV
dysfunction.
-blockers Postural hypotension Hypersensitivity
(e.g. prazosin)
ACE-inhibitors Cough, Hypotension, Hypersensitivity, Pregnancy,
(e.g. Lisinopril) Angioneurotic edema Bilateral renal artery stenosis
Angiotensin-II receptor Headache, Dizziness Hypersensitivity, Pregnancy,
blockers (e.g. Losartan) Bilateral renal artery stenosis
Antihypertensive therapy: Side-
effects and Contraindications
(Contd.)
Condition
• Pregnancy
• Coronary heart disease
• Congestive heart failure
Preferred Drugs
• Nifedipine, labetalol,
hydralazine, beta-blockers,
methyldopa, prazosin
• Beta-blockers, ACE
inhibitors, Calcium channel
blockers
• ACE inhibitors,
beta-blockers
1999 WHO-ISH guidelines
Causes of
Resistant Hypertension
 Improper BP measurement
 Excess sodium intake
 Inadequate diuretic therapy
 Medication
• Inadequate doses
• Drug actions and interactions (e.g., (NSAIDs), illicit drugs,
sympathomimetics, OCP)
• Over-the-counter drugs and some herbal supplements
 Excess alcohol intake
 Identifiable causes of HTN
take home message --------------
• Hypertension is a major cause of morbidity and mortality, and
needs to be treated
• It is an extremely common condition; however it is still under-
diagnosed and undertreated
• Hypertension is easy to diagnose and easy to treat
• Aim of the management is to save the target organ from the
deleterious effect
• Besides pharmacology we have other choices and one has to be
acquainted with that choice
• Life style modification should always be encouraged in all
Hypertensive patients
Any questions?
Que 1) Life style intervention for
management of hypertension includes all
except:
a) Regular aerobic activity 30 min /day
b) Salt intake to <6 gm./day
c) Attain and maintaining BMI >25k/m2
d) Diets rich in fruits and vegetables and restricted
content of saturated fats
e) Moderation of alcohol consumption
Que 2) Hypertension management is helpful
in the prevention of all except:
a) Coronary heart disease
b) Heart failure
c) Chronic kidney disease
d) Deep venous thrombosis
e) Cerebrovascular disease
Que 3) Isolated systolic hypertension is common
in:
a) Young
b) Elderly
c) Pregnancy
d) Blacks
Que 4) Antihypertensive agent
recommended for the protection of
cardiovascular diseases is:
a) Calcium channel blockers
b) Diuretics
c) ACE inhibitors
d) Alpha antagonists
e) Central sympatholytic
Que 5) Angiotensin Receptor Blockers play
Reno protective effect through all except:
a) Decreasing proteinuria
b) Decreasing intraglomerular pressure
c) Preventing endothelial dysfunction
d) Inhibiting conversion of angiotensin-I to
angiotensin –II
e) Blocking the angiotesin mediated renal
remodelling
Que 6) which of the following is the side
effect of ACE inhibitors:
a) Hyperkalaemia
b) Hypercalcemia
c) Hyperglycaemia
d) Hypertension
e) Hypermagnesemia
Que 7) Calcium channel blockers cause all
except:
a) Pedal oedema
b) Flushing
c) Hyperkalaemia
d) Headache
Que 8) : Safest drug for hypertension in
pregnancy is:
a) ACE inhibitors
b) Angiotensin receptor blockers
c) Diuretic
d) Methyldopa
Que9) the first line antihypertensive in
diabetic patients is:
a) Diuretics
b) Angiotensin converting enzyme inhibitors
c) Beta blockers
d) Calcium channel blockers
Que10) which of the following antihypertensive
agent is relatively contraindicated in congestive
cardiac failure:
a) ACE inhibitors
b) Angiotensin receptor blockers
c) Beta blockers
d) Diuretics

More Related Content

Similar to hypertension final.ppt

HYPERTENSION PPT.pptx detailed explanation
HYPERTENSION PPT.pptx detailed explanationHYPERTENSION PPT.pptx detailed explanation
HYPERTENSION PPT.pptx detailed explanation
jinsigeorge
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
chiapas52
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
RDScreenTV
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
derek462361
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
ssuser04ffc5
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
raul125935
 
Hypertension final
Hypertension finalHypertension final
Hypertension final
Kennedy Nyangweso
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
Sani191640
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
shirleyjohn4
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
RezaOskui1
 
hypertension final(1).ppt
hypertension final(1).ppthypertension final(1).ppt
hypertension final(1).ppt
AdelSALLAM4
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
AnonymousFCOOcn
 
hypertension final (1).ppt
hypertension final (1).ppthypertension final (1).ppt
hypertension final (1).ppt
MominaKhan66
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
Sani191640
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
Sani191640
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
TrngVnL2
 
5 hypertension final.ppt¹1111111111111111
5 hypertension final.ppt¹11111111111111115 hypertension final.ppt¹1111111111111111
5 hypertension final.ppt¹1111111111111111
marrahmohamed33
 
Hypertension diagnosis and management
Hypertension diagnosis and managementHypertension diagnosis and management
Hypertension diagnosis and management
shashank agrawal
 
Rational treatment of hypertension.pptx
Rational treatment of hypertension.pptxRational treatment of hypertension.pptx
Rational treatment of hypertension.pptx
mehrasa nikandish
 
hypertension and pathophysiology and nursing interventions
hypertension and pathophysiology and nursing interventionshypertension and pathophysiology and nursing interventions
hypertension and pathophysiology and nursing interventions
wajidullah9551
 

Similar to hypertension final.ppt (20)

HYPERTENSION PPT.pptx detailed explanation
HYPERTENSION PPT.pptx detailed explanationHYPERTENSION PPT.pptx detailed explanation
HYPERTENSION PPT.pptx detailed explanation
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
 
Hypertension final
Hypertension finalHypertension final
Hypertension final
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
 
hypertension final(1).ppt
hypertension final(1).ppthypertension final(1).ppt
hypertension final(1).ppt
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
 
hypertension final (1).ppt
hypertension final (1).ppthypertension final (1).ppt
hypertension final (1).ppt
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
 
5 hypertension final.ppt¹1111111111111111
5 hypertension final.ppt¹11111111111111115 hypertension final.ppt¹1111111111111111
5 hypertension final.ppt¹1111111111111111
 
Hypertension diagnosis and management
Hypertension diagnosis and managementHypertension diagnosis and management
Hypertension diagnosis and management
 
Rational treatment of hypertension.pptx
Rational treatment of hypertension.pptxRational treatment of hypertension.pptx
Rational treatment of hypertension.pptx
 
hypertension and pathophysiology and nursing interventions
hypertension and pathophysiology and nursing interventionshypertension and pathophysiology and nursing interventions
hypertension and pathophysiology and nursing interventions
 

More from Sudha Sudha

sonia-150921033640-lva1-app6892.ppt translation in prokaryotes
sonia-150921033640-lva1-app6892.ppt translation in prokaryotessonia-150921033640-lva1-app6892.ppt translation in prokaryotes
sonia-150921033640-lva1-app6892.ppt translation in prokaryotes
Sudha Sudha
 
36.ppt protein synthesis inhibitors prokaryotes
36.ppt protein synthesis inhibitors prokaryotes36.ppt protein synthesis inhibitors prokaryotes
36.ppt protein synthesis inhibitors prokaryotes
Sudha Sudha
 
Catabolism of Amino Acids.ppt degradation of aminoacids
Catabolism of Amino Acids.ppt degradation of aminoacidsCatabolism of Amino Acids.ppt degradation of aminoacids
Catabolism of Amino Acids.ppt degradation of aminoacids
Sudha Sudha
 
lecture27.ppt hypothalamus and pituitary gland
lecture27.ppt hypothalamus and pituitary glandlecture27.ppt hypothalamus and pituitary gland
lecture27.ppt hypothalamus and pituitary gland
Sudha Sudha
 
endocrine_physiology_2.ppt hypothalamic hormones
endocrine_physiology_2.ppt hypothalamic hormonesendocrine_physiology_2.ppt hypothalamic hormones
endocrine_physiology_2.ppt hypothalamic hormones
Sudha Sudha
 
30976_Blood_L3_Hemostasis_pt_08[1]3.ppt
30976_Blood_L3_Hemostasis_pt_08[1]3.ppt30976_Blood_L3_Hemostasis_pt_08[1]3.ppt
30976_Blood_L3_Hemostasis_pt_08[1]3.ppt
Sudha Sudha
 
4.1. KULIAH KEMAJIRAN INTRODUCTION.pdf
4.1. KULIAH KEMAJIRAN INTRODUCTION.pdf4.1. KULIAH KEMAJIRAN INTRODUCTION.pdf
4.1. KULIAH KEMAJIRAN INTRODUCTION.pdf
Sudha Sudha
 
Pregnancy.ppt
Pregnancy.pptPregnancy.ppt
Pregnancy.ppt
Sudha Sudha
 
Sex determination and differentiation.ppt
Sex determination and differentiation.pptSex determination and differentiation.ppt
Sex determination and differentiation.ppt
Sudha Sudha
 
female_anatomy.pptx
female_anatomy.pptxfemale_anatomy.pptx
female_anatomy.pptx
Sudha Sudha
 
inde222-11-10-2015-09-lect-Hillard-1.ppt
inde222-11-10-2015-09-lect-Hillard-1.pptinde222-11-10-2015-09-lect-Hillard-1.ppt
inde222-11-10-2015-09-lect-Hillard-1.ppt
Sudha Sudha
 
female_reproduction_hormone_cycle.ppt
female_reproduction_hormone_cycle.pptfemale_reproduction_hormone_cycle.ppt
female_reproduction_hormone_cycle.ppt
Sudha Sudha
 
Obesity & Coronary Heart Diseases.ppt
Obesity & Coronary Heart Diseases.pptObesity & Coronary Heart Diseases.ppt
Obesity & Coronary Heart Diseases.ppt
Sudha Sudha
 

More from Sudha Sudha (13)

sonia-150921033640-lva1-app6892.ppt translation in prokaryotes
sonia-150921033640-lva1-app6892.ppt translation in prokaryotessonia-150921033640-lva1-app6892.ppt translation in prokaryotes
sonia-150921033640-lva1-app6892.ppt translation in prokaryotes
 
36.ppt protein synthesis inhibitors prokaryotes
36.ppt protein synthesis inhibitors prokaryotes36.ppt protein synthesis inhibitors prokaryotes
36.ppt protein synthesis inhibitors prokaryotes
 
Catabolism of Amino Acids.ppt degradation of aminoacids
Catabolism of Amino Acids.ppt degradation of aminoacidsCatabolism of Amino Acids.ppt degradation of aminoacids
Catabolism of Amino Acids.ppt degradation of aminoacids
 
lecture27.ppt hypothalamus and pituitary gland
lecture27.ppt hypothalamus and pituitary glandlecture27.ppt hypothalamus and pituitary gland
lecture27.ppt hypothalamus and pituitary gland
 
endocrine_physiology_2.ppt hypothalamic hormones
endocrine_physiology_2.ppt hypothalamic hormonesendocrine_physiology_2.ppt hypothalamic hormones
endocrine_physiology_2.ppt hypothalamic hormones
 
30976_Blood_L3_Hemostasis_pt_08[1]3.ppt
30976_Blood_L3_Hemostasis_pt_08[1]3.ppt30976_Blood_L3_Hemostasis_pt_08[1]3.ppt
30976_Blood_L3_Hemostasis_pt_08[1]3.ppt
 
4.1. KULIAH KEMAJIRAN INTRODUCTION.pdf
4.1. KULIAH KEMAJIRAN INTRODUCTION.pdf4.1. KULIAH KEMAJIRAN INTRODUCTION.pdf
4.1. KULIAH KEMAJIRAN INTRODUCTION.pdf
 
Pregnancy.ppt
Pregnancy.pptPregnancy.ppt
Pregnancy.ppt
 
Sex determination and differentiation.ppt
Sex determination and differentiation.pptSex determination and differentiation.ppt
Sex determination and differentiation.ppt
 
female_anatomy.pptx
female_anatomy.pptxfemale_anatomy.pptx
female_anatomy.pptx
 
inde222-11-10-2015-09-lect-Hillard-1.ppt
inde222-11-10-2015-09-lect-Hillard-1.pptinde222-11-10-2015-09-lect-Hillard-1.ppt
inde222-11-10-2015-09-lect-Hillard-1.ppt
 
female_reproduction_hormone_cycle.ppt
female_reproduction_hormone_cycle.pptfemale_reproduction_hormone_cycle.ppt
female_reproduction_hormone_cycle.ppt
 
Obesity & Coronary Heart Diseases.ppt
Obesity & Coronary Heart Diseases.pptObesity & Coronary Heart Diseases.ppt
Obesity & Coronary Heart Diseases.ppt
 

Recently uploaded

MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
Dr. Rabia Inam Gandapore
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
Thangamjayarani
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 

Recently uploaded (20)

MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 

hypertension final.ppt

  • 2. Hypertension is defined as systolic blood pressure (SBP) of 140 mmHg or greater, diastolic blood pressure (DBP) of 90 mmHg or greater, or taking antihypertensive medication.
  • 3. Types of hypertension • Essential hypertension – 95% – No underlying cause • Secondary hypertension – Underlying cause
  • 4. Causes of Secondary Hypertension • Renal – Parenchymal – Vascular – Others • Endocrine • Miscellaneous • Unknown
  • 6. Blood Pressure Classification Normal <120 and <80 Prehypertension 120–139 or 80–89 Stage 1 Hypertension 140–159 or 90–99 Stage 2 Hypertension >160 or >100 BP Classification SBP mmHg DBP mmHg
  • 7. Incidence in India • 25% of urban population and 10 % of rural population suffer from hypertension • 70% of all hypertensive patients are stage I hypertension • 12% of all hypertensive suffer from isolated systolic hypertension
  • 8. Who are at risk ?
  • 9. Hypertension: Predisposing factors • Advancing Age • Sex (men and postmenopausal women) • Family history of cardiovascular disease • Sedentary life style & psycho-social stress • Smoking ,High cholesterol diet, Low fruit consumption • Obesity & wt. gain • Co-existing disorders such as diabetes, and hyperlipidaemia • High intake of alcohol
  • 10. Haemodynamic Pattern in Hypertension Young :  BP = CO X TPR Elderly :  BP =  CO X   TPR
  • 11. Aetiology of Systemic Hypertension Secondary HTN (05%) A. Renal (80%) • AGN • CGN, • CPN, • Polycyst. K.D • Renal Artery stenosis B. Endocrine • Adrenal • Primary aldosteronism • Cushing’s syndrome • Pheochromocytoma • Acromegaly • Exogenous hormone • Oral contraceptive • Glucocorticoids • Hypothyroidism & • Hyperparathyroidism Continue…
  • 12. Others – Coarctation of the aorta – Pregnancy Induced HTN (Pre-eclampsia) – Sleep Apnea Syndrome. Aetiology of Systemic Hypertension
  • 14. Diseases Attributable to Hypertension HYPERTENSION Gangrene of the Lower Extremities Heart Failure Left Ventricular Hypertrophy Myocardial Infarction Coronary Heart Disease Aortic Aneurym Blindness Chronic Kidney Failure Stroke Preeclampsia/ Eclampsia Cerebral Hemorrhage Hypertensive encephalopathy Adapted from Dustan HP et al. Arch Intern Med. 1996; 156: 1926-1935
  • 15. Target Organ Damage  Heart • Left ventricular hypertrophy • Angina or myocardial infarction • Heart failure  Brain • Stroke or transient ischemic attack  Chronic kidney disease  Peripheral arterial disease  Retinopathy
  • 16. CVD Risk  The BP relationship to risk of CVD is continuous, consistent, and independent of other risk factors.  Prehypertension signals the need for increased education to reduce BP in order to prevent hypertension.
  • 18. Clinical manifestations • No specific complains or manifestations other than elevated systolic and/or diastolic BP (Silent Killer ) • Morning occipital headache • Dizziness • Fatigue • In severe hypertension, epistaxis or blurred vision
  • 19. Self-Measurement of BP  Provides information on: 1. Response to antihypertensive therapy 2. Improving adherence with therapy 3. Evaluating white-coat HTN  Home measurement of >135/85 mmHg is generally considered to be hypertensive.  Home measurement devices should be checked regularly.
  • 20. Measuring Blood Pressure • Patient seated quietly for at least 5minutes in a chair, with feet on the floor and arm supported at heart level •An appropriate-sized cuff (cuff bladder encircling at least 80% of the arm) •At least 2 measurements Continue…
  • 21. • Systolic Blood Pressure is the point at which the first of 2 or more sounds is heard • Diastolic Blood Pressure is the point of disappearance of the sounds (Korotkoff 5th) Continue… Measuring Blood Pressure
  • 22. • Ambulatory BP Monitoring - information about BP during daily activities and sleep. • Correlates better than office measurements with target-organ injury. Continue… Measuring Blood Pressure
  • 24. Treatment Overview Goals of therapy Lifestyle modification Pharmacologic treatment  Algorithm for treatment of hypertension Follow up and monitoring
  • 25. Goals of Therapy Reduce Cardiac and renal morbidity and mortality. Treat to BP <140/90 mmHg or BP <130/80 mmHg in patients with diabetes or chronic kidney disease.
  • 26. Non pharmacological Treatment of hypertension Avoid harmful habits ,smoking ,alcohal Reduce salt and high fat diets Loose weight , if obese Regular exercise DASH diet
  • 27. Life style modifications • Lose weight, if overweight • Increase physical activity • Reduce salt intake • Stop smoking • Limit intake of foods rich in fats and cholesterol • increase consumption of fruits and vegetables • Limit alcohol intake
  • 28. Lifestyle Modification Modification Approximate SBP reduction (range) Weight reduction 5–20 mmHg / 10 kg weight loss Adopt DASH eating plan 8–14 mmHg Dietary sodium reduction 2–8 mmHg Physical activity 4–9 mmHg Moderation of alcohol consumption 2–4 mmHg
  • 30. Drug therapy for hypertension Class of drug Example Initiating dose Usualmaintenance dose Diuretics Hydrochlorothiazide 12.5 mg o.d. 12.5-25 mg o.d. -blockers Atenolol 25-50 mg o.d. 50-100 mg o.d. Calcium Amlodipine 2.5-5 mg o.d. 5-10 mg o.d. channel blockers -blockers prazosin 2.5 mg o.d 2.5-10mg o.d. ACE- inhibitors ramipril 1.25-5 mg o.d. 5-20 mg o.d. Angiotensin-II Losartan 25-50 mg o.d. 50-100 mg o.d. receptor blockers
  • 31. Diuretics Example: Hydrochlorothiazide • Act by decreasing blood volume and cardiac output • Decrease peripheral resistance during chronic therapy • Drugs of choice in elderly hypertensives Side effects- • Hypokalaemia • Hyponatraemia • Hyperlipidaemia • Hyperuricaemia (hence contraindicated in gout) • Hyperglycaemia (hence not safe in diabetes) • Not safe in renal and hepatic insufficiency
  • 32. Beta blockers Example: Atenolol, Metoprolol, nebivolol, • Block 1 receptors on the heart • Block 2 receptors on kidney and inhibit release of renin • Decrease rate and force of contraction and thus reduce cardiac output • Drugs of choice in patients with co-existent coronary heart disease Side effects- • lethargy, impotency, bradycardia • Not safe in patients with co-existing asthma and diabetes • Have an adverse effect on the lipid profile
  • 33. Calcium channel blockers Example: Amlodipine • Block entry of calcium through calcium channels • Cause vasodilation and reduce peripheral resistance • Drugs of choice in elderly hypertensives and those with co-existing asthma • Neutral effect on glucose and lipid levels Side effects Flushing, headache, Pedal edema
  • 34. ACE inhibitors Example: Ramipril, Lisinopril, Enalapril • Inhibit ACE and formation of angiotensin II and block its effects • Drugs of choice in co-existent diabetes mellitus, Heart failure Side effects- dry cough, hypotension, angioedema
  • 35. Angiotensin II receptor blockers Example: Losartan • Block the angiotensin II receptor and inhibit effects of angiotensin II • Drugs of choice in patients with co- existing diabetes mellitus Side effects- safer than ACEI, hypotension,
  • 36. Alpha blockers Example: prazosin • Block -1 receptors and cause vasodilation • Reduce peripheral resistance and venous return • Exert beneficial effects on lipids and insulin sensitivity • Drugs of choice in patients with co-existing BPH Side effects- Postural hypotension,
  • 37. Antihypertensive therapy: Side-effects and Contraindications Class of drugs Main side-effects Contraindications/ Special Precautions Diuretics Electrolyte imbalance, Hypersensitivity, Anuria (e.g. Hydrochloro- total and LDL cholesterol thiazide) levels, HDL cholesterol levels, glucose levels, uric acid levels -blockers Impotence, Bradycardia, (e.g. Atenolol) Fatigue Bradycardia, Conduction disturbances, Diabetes, Asthma, Severe cardiac failure
  • 38. Algorithm for Treatment of Hypertension Not at Goal Blood Pressure (<140/90 mmHg) (<130/80 mmHg for those with diabetes or chronic kidney disease) Initial Drug Choices Drug(s) for the compelling indications Other antihypertensive drugs (diuretics, ACEI, ARB, BB, CCB) as needed. With Compelling Indications Lifestyle Modifications Stage 2 Hypertension (SBP >160 or DBP >100 mmHg) 2-drug combination for most (usually thiazide-type diuretic and ACEI, or ARB, or BB, or CCB) Stage 1 Hypertension (SBP 140–159 or DBP 90–99 mmHg) Thiazide-type diuretics for most. May consider ACEI, ARB, BB, CCB, or combination. Without Compelling Indications Not at Goal Blood Pressure Optimize dosages or add additional drugs until goal blood pressure is achieved. Consider consultation with hypertension specialist.
  • 39. Choice of Drug Condition Preferred drugs Other drugs Drugs to be that can be used avoided Asthma Calcium channel -blockers/Angiotensin-II -blockers blockers receptor blockers/Diuretics/ ACE-inhibitors Diabetes -blockers/ACE Calcium channel blockers Diuretics/ mellitus inhibitors/ -blockers Angiotensin-II receptor blockers High cholesterol -blockers ACE inhibitors/ A-II -blockers/ levels receptor blockers/ Calcium Diuretics channel blockers Elderly patients Calcium channel -blockers/ACE- (above 60 years) blockers/Diuretics inhibitors/Angiotensin-II receptor blockers/- blockers BPH -blockers -blockers/ ACE inhibitors/ Angiotensin-II receptor blockers/ Diuretics/ Calcium channel blockers
  • 40. Class of drug Main side-effects Contraindications/ Special Precautions Calcium channel blockers Pedal edema, Headache Non-dihydropyridine (e.g. Amlodipine, CCBs (e.g diltiazem)– Diltiazem) Hypersensitivity, Bradycardia, Conduction disturbances, CHF, LV dysfunction. -blockers Postural hypotension Hypersensitivity (e.g. prazosin) ACE-inhibitors Cough, Hypotension, Hypersensitivity, Pregnancy, (e.g. Lisinopril) Angioneurotic edema Bilateral renal artery stenosis Angiotensin-II receptor Headache, Dizziness Hypersensitivity, Pregnancy, blockers (e.g. Losartan) Bilateral renal artery stenosis Antihypertensive therapy: Side- effects and Contraindications (Contd.)
  • 41. Condition • Pregnancy • Coronary heart disease • Congestive heart failure Preferred Drugs • Nifedipine, labetalol, hydralazine, beta-blockers, methyldopa, prazosin • Beta-blockers, ACE inhibitors, Calcium channel blockers • ACE inhibitors, beta-blockers 1999 WHO-ISH guidelines
  • 42. Causes of Resistant Hypertension  Improper BP measurement  Excess sodium intake  Inadequate diuretic therapy  Medication • Inadequate doses • Drug actions and interactions (e.g., (NSAIDs), illicit drugs, sympathomimetics, OCP) • Over-the-counter drugs and some herbal supplements  Excess alcohol intake  Identifiable causes of HTN
  • 43. take home message -------------- • Hypertension is a major cause of morbidity and mortality, and needs to be treated • It is an extremely common condition; however it is still under- diagnosed and undertreated • Hypertension is easy to diagnose and easy to treat • Aim of the management is to save the target organ from the deleterious effect • Besides pharmacology we have other choices and one has to be acquainted with that choice • Life style modification should always be encouraged in all Hypertensive patients
  • 45. Que 1) Life style intervention for management of hypertension includes all except: a) Regular aerobic activity 30 min /day b) Salt intake to <6 gm./day c) Attain and maintaining BMI >25k/m2 d) Diets rich in fruits and vegetables and restricted content of saturated fats e) Moderation of alcohol consumption
  • 46. Que 2) Hypertension management is helpful in the prevention of all except: a) Coronary heart disease b) Heart failure c) Chronic kidney disease d) Deep venous thrombosis e) Cerebrovascular disease
  • 47. Que 3) Isolated systolic hypertension is common in: a) Young b) Elderly c) Pregnancy d) Blacks
  • 48. Que 4) Antihypertensive agent recommended for the protection of cardiovascular diseases is: a) Calcium channel blockers b) Diuretics c) ACE inhibitors d) Alpha antagonists e) Central sympatholytic
  • 49. Que 5) Angiotensin Receptor Blockers play Reno protective effect through all except: a) Decreasing proteinuria b) Decreasing intraglomerular pressure c) Preventing endothelial dysfunction d) Inhibiting conversion of angiotensin-I to angiotensin –II e) Blocking the angiotesin mediated renal remodelling
  • 50. Que 6) which of the following is the side effect of ACE inhibitors: a) Hyperkalaemia b) Hypercalcemia c) Hyperglycaemia d) Hypertension e) Hypermagnesemia
  • 51. Que 7) Calcium channel blockers cause all except: a) Pedal oedema b) Flushing c) Hyperkalaemia d) Headache
  • 52. Que 8) : Safest drug for hypertension in pregnancy is: a) ACE inhibitors b) Angiotensin receptor blockers c) Diuretic d) Methyldopa
  • 53. Que9) the first line antihypertensive in diabetic patients is: a) Diuretics b) Angiotensin converting enzyme inhibitors c) Beta blockers d) Calcium channel blockers
  • 54. Que10) which of the following antihypertensive agent is relatively contraindicated in congestive cardiac failure: a) ACE inhibitors b) Angiotensin receptor blockers c) Beta blockers d) Diuretics